The global market for vascular sealants and surgical sealants has developed rapidly over the past 15 years. Because heart surgery is often a major procedure with multiple sutures, bleeding complications can occur. Vascular sealants are effectively used as a hemostatic agent to stop bleeding due to adhesion of diffuse surfaces with capillary hemorrhage during cardiac reoperation.
However, vascular sealants are not a substitute for surgical sutures. Vascular sealants received late approval in the United States, but some fibrin sealants have long been used for off-label applications in cardiovascular procedures in the United States and have been employed in the United States for emergency procedures.
Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/22846
Vascular sealants help improve treatment outcomes by reducing cross-contamination of the surgical site, and by protecting and protecting wounds and injuries from further infection or disease progression. The increasing incidence of endless injuries and surgical procedures is driving interest in state-of-the-art dressings.
Cost control increases the attractiveness of vascular sealants-related products. Some of the existing brands in the global vascular sealant market are PREVELEAK, Coseal, Seal-V, TRIDYNE, Vivostat, SURGIFLO, OMNEX, Technosil, Cryolife Inc. etc.
The demand for vascular sealants is driven by the nature of the case load and clinical needs of cardiovascular surgical procedures. An increase in cardiovascular interventions such as coronary reperfusion, valve repair procedures, coronary artery bypass grafting (CABG), etc. will drive the growth of the vascular sealants market.
According to American Heart Association Statistics, more than 469,000 CABG procedures were performed in the United States in 2008. Additionally, product approvals in the global vascular sealants market are expected to further accelerate the growth of the global market.
For example, in 2017, Gecko Biomedical received CE mark approval for Setalum bioabsorbable vascular sealant. However, some safety issues, such as the potential for overinflation, which can potentially damage vascular tissue when used in confined spaces, are factors limiting the growth of the vascular sealants market.
Request Table of Contents @ https://www.persistencemarketresearch.com/toc/22846
Market segmentation:
product type
- fibrin blood vessel sealant
- Collagen-based vascular sealant
- synthetic vascular sealant
end user
- hospital
- Cardiac Catheterization Lab
- Outpatient Surgical Center
Fibrinous vascular sealants are primarily used as adjuvant hemostasis in many cardiovascular and aortic procedures. Fibrin vascular sealant was one of the first approved vascular sealants and has been in use in the United States and Japan since 1998. Based on product type, the fiber vascular sealants segment is expected to contribute the highest share in the global vascular sealants market. Fibrinous vascular sealants are chosen in vascular surgery because they provide an effective means of sealing the anastomosis prior to vascular pressure and vascular clamp removal.
Of the three end-users of vascular sealants, the hospital end-user segment clearly dominates the global vascular sealants market during the forecast period, mainly owing to the high case load. In addition, various companies in the global vascular sealant market are taking various marketing strategies to penetrate products and expand sales, such as signing supply contracts with hospitals.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/22846
Effective use of vascular sealants is associated with cost savings and shorter hospital stays, ultimately increasing the demand for these products in hospital settings.
On the basis of regional presence, the global Vascular Sealants market is segmented into five major regions. North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America will continue to dominate the global vascular sealants market due to its high patient numbers. Europe is expected to hold the second largest market share in the global vascular sealants market owing to the increase in cardiovascular interventions.
The Vascular Sealants Market is integrated with a small number of international players operating in the global market. Key players identified in the global vascular sealants market include Sealantis Ltd., Baxter Healthcare Corporation, Mallinckrodt Inc., Tenaxis Medical Inc., Becton Dickinson and Company (Davol Inc.), Medtronic Inc., Vivostat A/S, Johnson & Johnson etc.
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – www.persistencemarketresearch.com